{"celex_id": "31997R0480", "uri": "http://publications.europa.eu/resource/cellar/5e8e7de9-9701-4ebc-aa11-74e47b613bb6", "type": "Regulation", "concepts": ["2069", "2773", "4062", "4381", "5055", "932"], "title": "Commission Regulation (EC) No 480/97 of 14 March 1997 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Common Customs Tariff\n", "header": "COMMISSION REGULATION (EC) No 480/97 of 14 March 1997 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Common Customs Tariff\nTHE COMMISSION OF THE EUROPEAN COMMUNITIES", "recitals": ",\nHaving regard to the Treaty establishing the European Community,\nHaving regard to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff (1), as last amended by Commission Regulation (EC) No 288/97 (2), and in particular Articles 9 and 12 thereof,\nWhereas, in the Uruguay Round talks, specified pharmaceutical products were to a certain extent granted exemption from customs duties; whereas the first review of the agreements relating to such products has now taken place within the WTO;\nWhereas, accordingly, Council Regulation (EC) No 467/97 (3) provides for duty-free treatment for certain active ingredients bearing an 'international non-proprietary name` (INN) from the World Health Organization and for certain products used for the manufacture of finished pharmaceuticals; whereas it also provides for the withdrawal of duty-free treatment as pharmaceutical products from certain INN products whose use is predominantly non-pharmaceutical;\nWhereas these amendments should be incorporated into Annex I to Council Regulation (EEC) No 2658/87;\nWhereas the measures provided for in this Regulation are in accordance with the opinion of the Tariff and Statistical Nomenclature Section of the Customs Code Committee,", "main_body": ["Annex I, Part Two, to Council Regulation (EEC) No 2658/87 is hereby amended in accordance with Annex I to this Regulation.", "Annex I, Part Three, Section II, to Council Regulation (EEC) No 2658/87 is hereby amended as follows:\n1. the products included in Annex II to this Regulation shall be added to Annex 3;\n2. the products included in Annex III to this Regulation shall be deleted from Annex 3;\n3. the products included in Annex IV to this Regulation shall be added to Annex 4;\n4. the products included in Annex V to this Regulation shall be added to Annex 6.", "This Regulation shall enter into force on the third day following its publication in the Official Journal of the European Communities.\nIt shall apply from 1 April 1997.\nThis Regulation shall be binding in its entirety and directly applicable in all Member States."], "attachments": "Done at Brussels, 14 March 1997.\nFor the Commission\nMario MONTI\nMember of the Commission\n(1) OJ No L 256, 7. 9. 1987, p. 1.\n(2) OJ No L 48, 19. 2. 1997, p. 7.\n(3) OJ No L 71, 13. 3. 1997, p. 1.\nANNEX I\n>TABLE>\nANNEX II\nList of international non-proprietary names (INNs) to be added to the list of products receiving duty-free treatment included in Annex 3 to Regulation (EEC) No 2658/87\n>TABLE>\nANNEX III\nList of international non-proprietary names (INNs) to be deleted from the list of products receiving duty-free treatment included in Annex 3 to Regulation (EEC) No 2658/87\n>\nTABLE POSITION>\nANNEX IV\nList of prefixes and suffixes which, in combination with the INNs, describe the salts, esters or hydrates of INNs, to be added to Annex 4 to Regulation (EEC) No 2658/87\nACETURATE\nN-ACETYLGLYCINATE\nACISTRATE\nACOXIL\nAMSONATE\nBENZATHINE\nBENZENESULPHONATE\nBEZOMIL\nBUCICLATE\nBUNAPSILATE\nBUTEPRATE\ntert-BUTYL\ntertiary BUTYL\nt-BUTYLAMINE\ntertiary BUTYLAMINE\nBUTYL ESTER\nCAMPHORSULPHONATE\nCAMPHOR-10-SULPHONATE\nCARBESILATE\np-CHLOROBENZENESULFONATE\np-CHLOROBENZENESULPHONATE\nCICLOTATE\nCIPIONATE\nCLOSILATE\nCLOSYLATE\nCROBEFATE\nCROMACATE\nCROMESILATE\nN-CYCLOHEXYLSULFAMATE\nCYCLOPENTANEPROPIONATE\nCYCLOTATE\nCYPIONATE\nDAPROPATE\nDEANIL\nDECIL\nDIBUDINATE\nDIBUNATE\nDIETHANOLAMINE\nDIGOLIL\nN,N-DIMETHYL-beta-ALANINE\nDIOLAMINE\nDISULPHATE\nDISULPHIDE\nDOCOSIL\nDOFOSFATE\nEDAMINE\nEDISYLATE\nEPOLAMINE\nERBUMINE\nETABONATE\n1,2-ETHANEDISULPHONATE\nETHANESULPHONATE\nETHANOLAMINE\nETHYLENEDIAMINE\nFARNESIL\nFENDIZOATE\nFLUOROSULPHONATE\nFOSTEDATE\nHEMISULPHATE\nHIBENZATE\nHYBENZATE\nHYCLATE\nHYDROGEN SULPHATE\nHYDROGEN SULPHITE\no-(4-HYDROXYBENZOYL)BENZOATE\n2-HYDROXYETHANESULPHONATE\nISOCAPROATE\nLAURIL\nLAURILSULFATE\nLAURILSULPHATE\nLAURYL\nLAURYLSULFATE\nLAURYLSULPHATE\nMEGALLATE\nMETEMBONATE\nMETHANESULPHONATE\n4-METHYLBICYCLO [2.2.2] OCT-2-ENE-1-\nCARBOXYLATE\nMETILSULFATE\nMETILSULPHATE\nMOFETIL\nOCTIL\nOLAMINE\nOXOGLURATE\n1,5-NAPHTHALENEDISULPHONATE\n2-NAPHTHALENESULPHONATE\nPANTOTHENATE SULPHATE\nPENDETIDE\nPIVOXETIL\nPOTASSIUM SULPHATE\nPROPIONATE DODECYL SULFATE\nPROPIONATE LAURYL SULPHATE\nPROXETIL\n1-PYRROLIDINEETHANOL\nSODIUM LAURIL SULFATE\nSODIUM LAURIL SULPHATE\nSODIUM LAURYL SULFATE\nSODIUM LAURYL SULPHATE\nSODIUM METHANESULFONATE\nSODIUM 3-SULFOBENZOATE\nSODIUM SULPHOBENZOATE\nSTEAGLATE\nSULPHINATE\nSULPHITE\nTENOATE\nTEPROSILATE\nTETRADECYL HYDROGEN PHOSPHATE\nTOFESILATE\np-TOLUENESULPHONATE\nTRICOFENATE\nTRIETHANOLAMINE\nTRIFLUTATE\nTROLAMINE\nTROMETAMOL\nTROMETHAMINE\nTROXUNDATE\nXINAFOATE\nANNEX V\nList of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be added to the list of products receiving duty free treatment included in Annex 6 to Regulation (EEC) No 2658/87\n>TABLE>"}